Jonathan Hauptman

6.7k citations
20 papers · 4.2k indexed · 2 hit papers · h-index 14
Topics
Pharmacology and Obesity Treatment (17 papers)Muscle metabolism and nutrition (6 papers)Diabetes Treatment and Management (4 papers)

In The Last Decade

Jonathan Hauptman

19 papers receiving 3.8k citations

Hit Papers

XENical in the Prevention of Diabetes in Obese Subjects (...1999202620082017200419994008001.2k

Peers

Jonathan Hauptman
Comparison fields: 5 of 99
  • Pharmacology 3.0k
  • Endocrinology, Diabetes and Metabolism 2.0k
  • Physiology 1.7k
  • Surgery 630
  • Public Health, Environmental and Occupational Health 502
Replace Mark Boldrin with:
Mark Boldrin United States
Charles Lucas United States
Priscilla Hollander United States
Matilde Sanchez United States
Kerstin Kempf Germany
Chrysi Koliaki Greece
Louise Bishop United States
Michael EJ Lean United Kingdom
Christine Beebe United States
Shilpa N Bhupathiraju United States
Jonathan Hauptman relative to Mark Boldrin United States Mark Boldrin's profile →
Citations per field
00.5×1.5×
Mark Boldrin · 1×
Citations per year

Countries citing papers authored by Jonathan Hauptman

Since Specialization
Citations

This map shows the geographic impact of Jonathan Hauptman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Hauptman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Hauptman more than expected).

Fields of papers citing papers by Jonathan Hauptman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Hauptman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Hauptman. The network helps show where Jonathan Hauptman may publish in the future.

Co-authorship network of co-authors of Jonathan Hauptman

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Hauptman. A scholar is included among the top collaborators of Jonathan Hauptman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Hauptman. Jonathan Hauptman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 55
2 13
3 34
4 9
5 412
6
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Studybreakdown →
1284
7 77
8 1
9 23
10 286
11 1
12 264
13
Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistatbreakdown →
705
14 66
15 225
16 13
17 472
18 210
19
Adrenergic blockade in pheochromocytoma.
12
20 21

About Jonathan Hauptman

Jonathan Hauptman is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Pharmacy, having authored 20 papers that have together received 4.2k indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (17 papers), Muscle metabolism and nutrition (6 papers) and Diabetes Treatment and Management (4 papers). The work is most often cited by research in Pharmacology (3.0k citations), Endocrinology, Diabetes and Metabolism (2.0k citations) and Pharmacy (382 citations). Jonathan Hauptman has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Mark Boldrin, Lars Sjöström, Jarl Torgerson, Charles Lucas, Steven B. Heymsfield, Jain Chung, Sarah Hampl, Jean‐Pierre Chanoine, Craig L. Jensen and David C. Robbins. Their work appears in journals such as JAMA, American Journal of Clinical Nutrition and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026